Home › Myasthenia Gravis › Pennsylvania
Myasthenia Gravis clinical trials in Pennsylvania
6 studies for Myasthenia Gravis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- The Childrens Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 1, 2026 · NCT06987539A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Penn State Milton S Hershey Medical Ctr, Hershey
- Childrens Hospital Of Philadelphia, Philadelphia
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Jul 31, 2026 · NCT05265273KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Thomas Jefferson University Hospital, Philadelphia
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Temple University Hospital, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Thomas Jefferson University, Philadelphia
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 11, 2025 · NCT05564936From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.